Lisbon 2017 Delegate Registration Programme Exhibition Virtual Exhibition Satellites OneWorld Travel Discount
escrs app advert


Search Title by author or title

Clinical results of endocyclophotocoagulation in patients with refractory glaucoma: experience at the Oftalmosalud Eye Institute in Lima, Peru

Poster Details

First Author: M.Ponte-Davila PERU

Co Author(s):    J. Izquierdo Villavicencio   F. Quezada Baltodano   I. Ramirez   A. Gonz�Ã�¡lez M�Ã�©ndez   L. Saldarriaga   R. Araujo     

Abstract Details


To describe the efficacy of the results in the treatment of endocyclophotophotocoagulation (ECP) in refractory glaucoma.


Research Department, Oftalmosalud Eye Institute, Lima-Peru, Av. Javier Prado Este 1142, San Isidro, Lima, Peru


Retrospective, longitudinal and interventional study was carried out in patients undergoing ECP at the institute of eyes Oftalmosalud with a 2-year follow-up. In 2011, patients with refractory glaucoma diagnosis were evaluated, visual acuity better corrected (BCVA), intraocular pressure IOP), preoperative, 1 day, 1 month, 6 months, 1 year and 2 years and preoperative antiglaucomatous drugs, 1 year and 2 years.


We studied 50 eyes, 24 men and 15 women with mean age �Â�± SD (65.00�Â�±16.25). Statistically, the mean�Â�±SD preoperative corrected visual acuity improved from preoperative to 2 years 0.86�Â�±0.81 to 0.74�Â�±1.02.There was a significant difference in preoperative BCVA vs 1 day (p=0.00), not being significant at preoperative vs 2 years (p =0.140). In the mean�Â�±SD of preoperative intraocular pressure obtained from preoperative to 2 years follow-up 22.30�Â�±8.73 mmHg at 13.02�Â�±4.61 mmHg. The reduction was significant preoperative up to 2 years of follow-up (p = 0.00). In the antiglaucomatous treatment the mean�Â�±SD preoperative up to 2 years was 2.08�Â�±0.87 to 1.60�Â�±0.94.Being significant at 2 years (p=0.016). Postoperative complications: choroidal bleeding (1.9%), pupillary membrane (3.8%) and maximum hypertension 50 mmHg (1.9%).


Our results suggest that ECP provides a safe and adequate IOP that decreases conservative visual acuity, with a very low rate of complications and reoperations, which can be performed alone or in combination with cataract surgery.

Financial Disclosure:


Back to Poster listing